Amino acid biology is fundamental to life, regulating biological pathways critical to health. A variety of conditions occur when amino acid pathways become dysregulated. Pronutria Biosciences is developing first-in-class solutions to these conditions with a focus on amino acid biology. Using insights from a clinically validated body of evidence, we are pioneering new nutritional and therapeutic modalities: amino acid biologics. This novel approach allows us to precisely target biology that was previously inaccessible, providing a unique opportunity to address a variety of serious nutritional and medical conditions, such as muscle, metabolic, neurological, liver disorders and inborn errors of metabolism. Founded by Flagship VentureLabs, privately-held Pronutria Biosciences is based in Cambridge MA.
Date | Amount | Type | Investors | Valuation |
---|---|---|---|---|
05/28/15 | $39,000,000 | Series C |
Fidelity Management & Research Company Flagship Ventures | undisclosed |